Skip to Main Content

Author Details

Ying Xu
2007
41
18
PMIDPaper TitleJournal TitlePublished Year
37348833Comparisons of Medical Cost Trajectories Between Non-Hispanic Black and Non-Hispanic White Patients With Newly Diagnosed Localized Prostate Cancer.2023
37676663Financial Outcomes of "Bagging" Oncology Drugs Among Privately Insured Patients With Cancer.2023
36099068Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured.J Natl Cancer Inst2022
34350376Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market.JNCI Cancer Spectr2021
33556275Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.Annals of Internal Medicine2021
34269395Statistical modeling of longitudinal medical cost trajectory: renal cell cancer care cost analyses.Biostatistics2020
30711063Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.Value in Health2019
31688604Racial Differences in the Incidence and Survival of Patients With Neuroendocrine Tumors.Pancreas2019
30640382Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting.JAMA Internal Medicine2019
31286464Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.PharmacoEconomics2019
30849005Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives.J Oncol Pract2019
30832966Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma.Value in Health2019
30716524Local Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based Study.Int J Radiat Oncol Biol Phys2019
29682693Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors.PharmacoEconomics2018
30442902Pre-existing Symptoms and Healthcare Utilization Prior to Diagnosis of Neuroendocrine Tumors: A SEER-Medicare Database Study.Scientific Reports2018
29485067Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study.Int J Radiat Oncol Biol Phys2018
28238592Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.Lancet Oncology, The2017
28642335Carcinoid Syndrome and Costs of Care During the First Year After Diagnosis of Neuroendocrine Tumors Among Elderly Patients.Oncologist2017
28448665Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.JAMA Oncology2017
28444105Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors.Annals of Oncology2017
28570719Association Between Quality of Care for Breast Cancer and Health Insurance Exchange Coverage: An Analysis of Use of Radiation Therapy After Breast-Conserving Surgery.JAMA Oncol2017
28471711Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.Journal of Clinical Oncology2017
26911407Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors.Oncologist2016
26797253Granulocyte growth factor use in elderly patients with non-Hodgkin's lymphoma in the United States: adherence to guidelines and comparative effectiveness.Support Care Cancer2016
26315553Octreotide long-acting repeatable among elderly patients with neuroendocrine tumors: a survival analysis of SEER-Medicare data.Cancer Epidemiology Biomarkers and Prevention2015
24557339First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.Breast Cancer Res Treat2014
24268788Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation.Int J Radiat Oncol Biol Phys2014
24912900Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study.J Clin Oncol2014
24676892Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: a population-based analysis.Cancer2014
21537147A population-based study of the quality of care in the diagnosis of large (â¿¥5 cm) soft tissue sarcomas.Am J Clin Oncol2012
22550197Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer.JAMA2012
22433769Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans.Value Health2012
21135274Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care.J Clin Oncol2011
21395352Economic burden of renal cell carcinoma in the US: Part II--an updated analysis.PharmacoEconomics2011
21395351Economic burden of renal cell carcinoma: Part I--an updated review.PharmacoEconomics2011
20014181Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study.Cancer2010
21265391Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients.Journal of Supportive Oncology2010
19801315Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.J Am Coll Surg2009
19289624Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.J Clin Oncol2009
17887806Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.PharmacoEconomics2007
17567835Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy.Cancer2007
  • 1 - 41 of 41

Recommended Authors

Collaborators

The University of Texas MD Anderson Cancer Center
Co-authored papers 15
Co-authored papers 11
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
Co-authored papers 9
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Co-authored papers 4
Co-authored papers 2
James Cancer Center, The Ohio State University
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Memorial-Sloan Kettering Cancer Center
Co-authored papers 1
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1